GATAD2A Inhibitors, though not directly targeting GATAD2A itself, encompasses a spectrum of compounds that influence the activity of GATAD2A through indirect mechanisms primarily associated with chromatin remodeling and histone modification. GATAD2A, a component of the NuRD (Nucleosome Remodeling and Deacetylase) complex, is instrumental in transcriptional regulation and chromatin structure modulation. The inhibitors in this class, primarily histone deacetylase (HDAC) inhibitors, impact these processes by altering the acetylation status of histones, thereby influencing the chromatin environment in which GATAD2A operates. This category includes various chemical entities, ranging from natural compounds to synthetic molecules, each exhibiting unique interactions with HDAC enzymes. By increasing histone acetylation levels, these inhibitors induce a more relaxed chromatin state, which can indirectly affect GATAD2A's role in chromatin remodeling and gene expression regulation. The mechanisms of action of these compounds vary, but they converge on the inhibition of HDAC activity, leading to changes in the chromatin landscape that can potentially modulate the function of chromatin-associated proteins like GATAD2A.
GATAD2A Inhibitors class showcases a remarkable diversity in molecular structure and biochemical properties. The compounds, such as Trichostatin A, Vorinostat, and Valproic Acid, differ significantly in their chemical makeup and interaction patterns with HDAC enzymes. Despite this diversity, their common objective is to modulate the acetylation state of histones, an essential factor in chromatin dynamics and gene expression regulation. These inhibitors interact with HDACs by occupying the enzyme's active site or altering its conformation, thus preventing the deacetylation of histones. This inhibition results in an accumulation of acetylated histones, leading to a more open chromatin structure, which in turn can influence the activity of chromatin-remodeling complexes like NuRD. The variety in their action and structure reflects the complexity of targeting chromatin remodeling processes and highlights the intricate interplay between histone modifications and the regulation of chromatin structure. This class of compounds, through its influence on the chromatin landscape, underscores the significance of epigenetic regulation in cellular processes and the potential for indirect modulation of specific components like GATAD2A involved in these complex networks.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, a histone deacetylase inhibitor, could modify chromatin structure, indirectly affecting GATAD2A's function in chromatin remodeling. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate acts as a histone deacetylase inhibitor, potentially influencing GATAD2A activity by altering chromatin dynamics. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a potent histone deacetylase inhibitor that may indirectly modulate GATAD2A's role in nucleosome remodeling. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin, by inhibiting histone deacetylases, could affect chromatin structure and indirectly impact GATAD2A function. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat is another histone deacetylase inhibitor that may influence GATAD2A's involvement in chromatin remodeling and transcriptional regulation. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat, a histone deacetylase inhibitor, could indirectly affect the function of GATAD2A in chromatin structure regulation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat inhibits histone deacetylases, potentially impacting GATAD2A's role in transcriptional regulation through chromatin remodeling. | ||||||
CI 994 | 112522-64-2 | sc-205245 sc-205245A | 10 mg 50 mg | $99.00 $536.00 | 1 | |
Tacedinaline, a histone deacetylase inhibitor, could indirectly modulate GATAD2A's activity in the context of chromatin structure and function. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $62.00 $250.00 $1196.00 | ||
Chidamide, by inhibiting histone deacetylases, might influence GATAD2A-associated transcriptional regulation and chromatin remodeling. | ||||||
JNJ-26481585 | 875320-29-9 | sc-364515 sc-364515A | 5 mg 50 mg | $321.00 $1224.00 | ||
Quisinostat, another histone deacetylase inhibitor, could have an indirect effect on GATAD2A's function in chromatin dynamics and gene expression regulation. | ||||||